These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 39738)

  • 1. [The stimulant effect of neuroleptics: myth or reality?].
    Colonna L; Petit M
    Encephale; 1979; 5(3):239-42. PubMed ID: 39738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between pD2 and pA2 of neuroleptics.
    Morgenstern R; Strutz G
    Acta Biol Med Ger; 1980; 39(1):133-9. PubMed ID: 6106991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sedative action of low doses of dopaminergic agents.
    Maj J; Przewlocka B; Kukulka L
    Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics.
    Koek W; Colpaert FC
    J Pharmacol Exp Ther; 1993 Oct; 267(1):181-91. PubMed ID: 7901392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of rat motility response to apomorphine: a simple model for studying preferential blockade of brain dopamine receptors mediating sedation.
    Montanaro N; Vaccheri A; Dall'Olio R; Gandolfi O
    Psychopharmacology (Berl); 1983; 81(3):214-9. PubMed ID: 6139839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization.
    Braga PQ; Dias FR; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2009 Aug; 93(2):128-33. PubMed ID: 19414026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of pharmacological data in the choice of antipsychotic drugs].
    Poirier-Littré MF
    Encephale; 1992 Sep; 18 Spec No 3():459-66. PubMed ID: 1364080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphasic action of apomorphine on motility of the rat. I. Dose-effect relationship in exploratory and basal motility].
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):374-80. PubMed ID: 7236417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M; Leonard BE
    J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
    Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics].
    Vasar EE; Nurk AM; Maĭmets MO; Allikmets LKh
    Biull Eksp Biol Med; 1985 Jan; 99(1):72-4. PubMed ID: 2857100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of classical and atypical neuroleptics on apomorphine-induced behavioural changes and on extinction of a conditioned avoidance response.
    Serra G; Van Ree JM; de Wied D
    J Pharm Pharmacol; 1983 Apr; 35(4):255-7. PubMed ID: 6133940
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
    Dunne F; O'Halloran A; Kelly JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms.
    Braga PQ; Dias FR; Carey RJ; Carrera MP
    Behav Brain Res; 2009 Dec; 204(1):169-74. PubMed ID: 19520118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diphasic action of apomorphine on motility in the rat. II. Time aspects of the effect of a single dose].
    Vaccheri A; Gandolfi O; Dall'Olio R; Montanaro N
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):381-6. PubMed ID: 7236418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.